Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
374M
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
63.9M
-
Shares change
-
-4.82M
-
Total reported value, excl. options
-
$296M
-
Value change
-
-$62.7M
-
Put/Call ratio
-
0.16
-
Number of buys
-
66
-
Number of sells
-
-69
-
Price
-
$4.63
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) as of Q3 2019
157 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share as of Q3 2019.
STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.9M shares
of 374M outstanding shares and own 17.06% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (6.49M shares), Neuberger Berman Group LLC (5.4M shares), Levin Easterly Partners LLC (5.02M shares), BlackRock Inc. (4.94M shares), VANGUARD GROUP INC (4.4M shares), Russell Investments Group, Ltd. (4.01M shares), Partner Fund Management, L.P. (3.11M shares), RENAISSANCE TECHNOLOGIES LLC (2.75M shares), Indaba Capital Management, L.P. (2.72M shares), and RTW INVESTMENTS, LP (2.11M shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.